Elon Musk-run brain-machine interface company Neuralink is preparing to launch clinical trials that will implant brain chips in humans. Elon Musk's brain-interface technology company Neuralink may start implanting microchips in human beings from 2022. Neuralink is preparing to launch clinical trials that will implant brain chips in humans. Cofounded by Elon Musk in 2016, Neuralink is working on a chip that would be implanted in our brains to record and stimulate brain activity. This chip is being created for medical applications such as treating serious spinal cord injuries and neurological disorders.

A brain-computer interface (BCI) is a technology to provide direct communication between the brain and an external device. In this project, we have utilized noninvasive electroencephalography (EEG) to record and decode neural activity during the observation and mental imagery of visual stimuli. Our platform has demonstrated successful discrimination between face and scene image categories during visual observation and imagery periods. Additionally, we have shown above chance decoding accuracy during real-time prediction of face and scene imagery and resting state. This platform provides further insight into the use of visual imagery, a protocol that has not yet been much tested for BCI applications.

Elon Musk appears close to beginning the first ever human trials of his brain-computer interface technology. A new job posting for a'Clinical Trial Director' at Neuralink reveals that the neurotech startup is preparing to take its brain chip research to the next stage. Neuralink has already conducted trials on pigs and monkeys, including a successful experiment involving a nine-year-old macaque capable of playing video games using only its mind. The firm eventually hopes to use the technology to allow "human-AI symbiosis". Early human trials, which Mr Musk said last month will take place in 2022, will likely involve people with paralysis using Neuralink's interface to gain direct neural control of a computer cursor.

Elon Musk has demonstrated the Neuralink brain chip in a pig, a monkey and we could soon see preform in a human brain. The firm posted a new job listing for a clinical trial director, which says the right candidate will'work closely with some of the most innovative doctors and top engineers, as well as working with Neuralink's first Clinical Trial participants.' The position is based in Fremont, California and provides the candidate with commuter benefits, meals and'an opportunity to change the world.' It also indicates that the job will mean leading and building'the team responsible for enabling Neuralink's clinical research activities,' as well as adhering to regulations. Neuralink posted a new job listing, first spotted by Bloomberg, for a clinical trial director, which says the right candidate will'work closely with some of the most innovative doctors and top engineers, as well as working with Neuralink's first Clinical Trial participants Although the posting does not say when the trials will begin, Musk revealed last month that they are less than a year away - meaning human trials could start this year.

The billionaire entrepreneur Elon Musk's brain chip startup is preparing to launch clinical trials in humans. Musk, who co-founded Neuralink in 2016, has promised that the technology "will enable someone with paralysis to use a smartphone with their mind faster than someone using thumbs". The Silicon Valley company, which has already successfully implanted artificial intelligence microchips in the brains of a macaque monkey named Pager and a pig named Gertrude, is now recruiting for a "clinical trial director" to run tests of the technology in humans. "As the clinical trial director, you'll work closely with some of the most innovative doctors and top engineers, as well as working with Neuralink's first clinical trial participants," the advert for the role in Fremont, California, says. "You will lead and help build the team responsible for enabling Neuralink's clinical research activities and developing the regulatory interactions that come with a fast-paced and ever-evolving environment."

Researchers have built a sensor capable of recording signals from the human brain in record-breaking detail, opening up new possibilities for brain-computer interfaces. A team of engineers and surgeons, led by University of California San Diego professor Shadi Dayeh, used a densely packed grid embedded with thousands of electrocorticography (EC0G) sensors to allow them to read activity from the brain's cortex in 100 times higher resolution than existing technologies. Early applications could include surgeons receiving ultra clear brain signal information, providing better guidance for removing tumours without damaging healthy tissue, as well as surgically treating drug-resistant epilepsy. Longer-term, the brain device could be used as a permanent wireless implant to assist people living with paralysis or other neurodegenerative diseases like Parkinson's, which can be treated with electrical stimulation. Beyond that, the ECoG technology could be developed for use in the emerging field of brain-computer interfaces, which have a huge range of potential applications – from controlling a computer just by thinking, to streaming music directly to your brain.

The last time I saw my friend James was at the townie bar near our old high school. He had been working in roofing for a few years, no longer a rail-thin teenager with lank hippie hair. I had just gotten back from a stint with the Peace Corps in Turkmenistan. We reminisced about the summer after our freshman year, when we were inseparable--adventuring in the creek that sliced through the woods, debating the merits of Batman versus the Crow, watching every movie in my father's bootlegged VHS collection. I had no idea what I wanted to do next.

A 62-year-old Australian man paralyzed following his diagnosis with amyotrophic lateral sclerosis (ALS) has become the first individual to send out a message on social media using a brain-computer interface, RT reported. Brain-computer interfaces (BCI) are the next big thing in technology. While some people like Elon Musk want to use it to enhance human experiences as early as next year, others such as Synchron, whose interface helped Australian Philip O'Keefe send out his first tweet, want to develop it as a prosthesis for paralysis and treat other neurological diseases such as Parkinson's disease in the future, the company said in a press release. Synchron's BCI works through its brain implant called Stentrode that does not require any brain surgery to be installed. Instead, the company leverages the intentional techniques that are commonly used to treat stroke to implant the Stentrode via the jugular vein, the press release said.

Survivors of a severe brain or spinal cord injury are often left with a lifelong disability that impacts their lives negatively. A common problem faced by them is permanent paralysis due to the damage caused to their nervous system. The most severe form of paralysis is tetraplegia, as people suffering from it have lost control of both their arms and legs. Researchers have been working for years to build devices that tetraplegic patients can control using their thoughts and perform certain activities independently. Different institutions and organizations have been working on building seamless mind-controlled robots to perform various tasks.

A paralysed man has made the first "direct-thought tweet" after having a computer chip implanted in his brain. Philip O-Keefe, a 62-year-old Australian who suffers from amyotrophic lateral sclerosis (ALS), composed and posted the tweet using only his thoughts via a brain computer interface developed by neurotech startup Synchron. I created this tweet just by thinking it," stated the tweet, which was posted to the account of Synchron CEO Thomas Oxley. After sharing the initial tweet, Mr O'Keefe posted seven further tweets replying to questions from Twitter users. "My hope is that I'm paving the way for people to tweet through thoughts," the final one stated. Follow live coverage of Nasa's James Webb Space Telescope launch James Webb Space Telescope successfully launched by Nasa Crypto experts make bitcoin price predictions for 2022 Follow live coverage of Nasa's James Webb Space Telescope launch The Stentrode device was first implanted in April 2020 after Mr O'Keefe's condition deteriorated to a point that he was unable to engage in work-related or other independent activities. It was inserted through the jugular vein in order to avoid invasive brain surgery, and has since allowed him to reconnect with loved ones and colleagues via email, as well as play simple computer-based gamed like Solitaire. "When I first heard about this technology, I knew how much independence it could give back to me," Mr O'Keefe said after posting the tweet, according to a press release from Synchron. "The system is astonishing, it's like learning to ride a bike – it takes practice, but once you're rolling, it becomes natural.